N-nitroso Imidapril

N-nitroso Imidapril is a chemical compound that belongs to the class of nitrosamines. It is a derivative of Imidapril, which is an angiotensin-converting enzyme inhibitor (ACE inhibitor) used for the treatment of hypertension and heart failure. Nitrosamines are carcinogenic compounds that are formed by the reaction of nitrites and secondary amines in acidic conditions. The usage of N-nitroso Imidapril is limited due to its carcinogenic properties. Nitrosamines are known to cause cancer in animals and are suspected to be carcinogenic in humans. Therefore, the use of N-nitroso Imidapril in pharmaceuticals and other products is highly regulated. The compound is classified as a Group 2A carcinogen by the International Agency for Research on Cancer, indicating that it is probably carcinogenic to humans. Chemically, N-nitroso Imidapril is a yellowish-orange powder that is slightly soluble in water and ethanol. Its molecular formula is C13H18N4O3 and its molecular weight is 278.31 g/mol. The compound is unstable and decomposes rapidly in the presence of light and air. It is also sensitive to heat, which can cause it to decompose and release toxic gases. In conclusion, N-nitroso Imidapril is a carcinogenic compound that should be handled with extreme caution. Its usage is limited due to its potential to cause cancer in humans and animals. Further research is needed to understand the full extent of its toxicity and to develop safer alternatives.